GSA Capital Partners’s Prelude Therapeutics PRLD Stock Holding History

GSA Capital Partners’s Portfolio PRLD Stock Details PRLD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$108K	Buy
2025 Q2	$58K	Buy
2023 Q4	–	Sell
2023 Q3	$218K	Sell
2023 Q2	$328K	Buy
2023 Q1	$271K	Sell
2022 Q4	$289K	Sell
2022 Q3	$358K	Buy
2022 Q2	$191K	Buy
2022 Q1	$160K	Buy